CONTACT USALL ONLINE COURSESMMS HOME
Electronic Prescribing Education
Terminating the Physician-Patient Relationship

Course Information

Introduction

Risk Management Guidelines:Q & A

Case 1

Case 2

Case 3

Case 4

Case 5

Conclusion

Course Materials

Proceed to Exam

Copyright Policy



My Certification Profile

860 Winter Street
Waltham MA 02451
(800) 322-2303 or
(781) 893-4610
© Copyright

COURSE INFORMATION

COURSE OBJECTIVES

Questions concerning how, when, and whether to terminate the professional relationship with a patient are asked by numbers of physicians who find themselves unable to please, to treat, or to work with certain patients.  Fear of being involved in litigation alleging abandonment leads many physicians to continue an unsatisfactory professional relationship with a patient.  This article addresses some of the reasons for which termination might-and might not-be appropriate and the steps that should be included in the termination process.  It also highlights some of the issues that might make termination not a straight road but a circuitous path.

After reading this article, physicians will be able to:

  • Name at least seven reasons for which termination might be indicated.
  • Identify five elements that should be included in a termination letter.
  • Describe three situations that must be avoided if the physician wishes to avoid an allegation of abandonment.

Return to top

COURSE CREDIT

DEADLINE for completing the course is December 31, 2007.

The Massachusetts Medical Society designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.

Participants will receive a confidential report of their examination score. You must answer 5 out of 6 questions correctly to receive AMA PRA Category 1 Credit™.  A confirmation of credit will be issued at the end of the course to those who successfully complete the examination.

Return to top

COURSE FEES

This course and all associated course materials are available free of charge. An opportunity to complete exam and receive  1 AMA PRA Category 1 Credit™ for a nominal fee is available at the end of the course. The course fees are as follows:

Massachusetts Medical Society (MMS) Member/ProMutual Group policy holder: $10

Non-MMS member/Non-ProMutual Group policy holder: $20

Return to top

COURSE FACULTY

Jointly sponsored by the Massachusetts Medical Society and ProMutual Group.

Author:

Linda Greenwald, Editor, Risk Management Publications, ProMutual Group

Advisors:

Caroline Carregal, Director of Continuing Education and Certification, Massachusetts Medical Society (MMS)

Maureen Mondor, Vice-President, Risk Management Department, ProMutual Group

Faculty Disclosure Statement:

The course advisors and author have nothing to disclose with regard to commercial support or discussion of off-label, investigational uses.

Online Developers:

Kathleen Bellisle, Manager, Online and Distance Learning, MMS

Return to top

COURSE MATERIALS

(Requires free Adobe Reader download)

Download Adobe Reader  

Return to Top

DISCLOSURE/COMMERCIAL SUPPORT

This information is intended to provide general guidelines for risk management. It is not intended and should not be construed as legal advice.

Disclosure:

Author: Linda Greenwald, Editor, Risk Management Publications, ProMutual Group has no financial interests or relationships with commercial manufacturers to disclose.

Advisors:

Caroline Carregal, Director of Medical Education Services, Massachusetts Medical Society has no financial interests or relationships with commercial manufacturers to disclose.

Maureen Mondor, Vice President, Risk Management Department, ProMutual Group has no financial interests or relationships with commercial manufacturers to disclose.

Off-label Disclosure:

This course does not include any discussion of an off-label use of a commercial product or an investigational use not yet approved for any purpose by the FDA.

Commercial Support:

No commercial support was received for this program.

Content Disclaimer

The views expressed are not necessarily those of the Massachusetts Medical Society.

Return to top

Contact us at continuingeducation@mms.org.

Next Page: Introduction

Accreditation Privacy Policy Feedback